The effects of a randomized trial of brief forms of stress management on RAGE‐associated S100A8/A9 in patients with breast cancer undergoing primary treatment

@chadinabhan @crisbergerot @montypal @PauloBergerot @shilpaonc @WilliamDale_MD @CMShannon_ @GlopesMd @DarcyBurbage @chemobrainfog @oncology_bg @EnriqueSoto8 Here’s a study addressing your favorite part of what Dr. Bergerot discussed (all of which was pret…

Brief, postsurgical, group‐based stress management reduces RAGE‐associated s100A8/A9 ligand levels during primary treatment for breast cancer. https://t.co/7LHcHTtz7R https://t.co/IhHBy2LSqs

乳がんのコントロール。RAGE-associated S100A8/A9 #AGE https://t.co/95OaDXAuGT

Brief, postsurgical, group‐based stress management reduces RAGE‐associated s100A8/A9 ligand levels during primary treatment for #BreastCancer. https://t.co/LZQuPCCqb6 @SylvesterCancer